10/28, 7:35 AM (Source: TeleTrader)
more TeleTrader news


Chart for: Sanofi SA

Sanofi Q3 sales jump 10% to €10.4 billion

Sanofi S.A. said on Thursday that its revenue soared 10.1% in the third quarter of 2021 to reach €10.4 billion, mainly due to the rising sales of its Dupixent drug, flu vaccines as well as the company's consumer healthcare services. Sanofi's net income rose 18.7% to €2.32 billion, with earnings per share of €1.85.

"Sanofi has delivered outstanding financial results in the third quarter... As a result of our sales performance and strong earnings, we have upgraded our full-year EPS guidance growth... Aligned with our contract with society and leading up to COP 26, we have set ourselves new ambitious ESG targets to reduce carbon emissions and accelerate our actions in fighting global climate change," CEO Paul Hudson noted.

Breaking the News / ND